@article{3104585,
    title = "Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents",
    author = "Mina, R. and Joseph, N.S. and Gay, F. and Kastritis, E. and Petrucci, M.T. and Kaufman, J.L. and Montefusco, V. and Gavriatopoulou, M. and Patriarca, F. and Omedé, P. and Boise, L.H. and Roussou, M. and Giuliani, N. and Oliva, S. and Offidani, M. and Belotti, A. and Jaye, D.L. and De Paoli, L. and Terpos, E. and Lonial, S. and Boccadoro, M. and Nooka, A.K. and Dimopoulos, M.A.",
    journal = "Blood cancer journal",
    year = "2020",
    volume = "10",
    number = "4",
    publisher = "Springer Nature BV",
    doi = "10.1038/s41408-020-0307-4",
    keywords = "antineoplastic agent;  creatinine;  immunoglobulin heavy chain;  immunomodulating agent;  lactate dehydrogenase;  proteasome inhibitor, autologous stem cell transplantation;  bone marrow cell;  c musculoaponeurotic fibrosarcoma oncogene;  cancer patient;  cancer prognosis;  cancer survival;  chromosome 14;  chromosome translocation;  chromosome translocation t(11;14);  clinical feature;  creatinine blood level;  fluorescence in situ hybridization;  human;  hypercalcemia;  immunotherapy;  lactate dehydrogenase blood level;  Letter;  multiple myeloma;  oncogene;  progression free survival;  adult;  aged;  autotransplantation;  chromosome 16;  female;  gene translocation;  genetics;  hematopoietic stem cell transplantation;  male;  middle aged;  mortality;  multiple myeloma;  pathology;  prognosis;  survival rate;  very elderly, Adult;  Aged;  Aged, 80 and over;  Chromosomes, Human, Pair 14;  Chromosomes, Human, Pair 16;  Female;  Hematopoietic Stem Cell Transplantation;  Humans;  Male;  Middle Aged;  Multiple Myeloma;  Prognosis;  Survival Rate;  Translocation, Genetic;  Transplantation, Autologous"
}